Vitamin D3 for Life

Live Enlightened

Article

VDR Abundance, Regulation and Receptor Turnover: Evidence Synthesis

Previous related pagePathogenic VDR Mutations and Hereditary Vitamin D-Resistant Rickets: Evidence SynthesisNext related pageVDR FokI Polymorphism and Immune-Cell Function: Full Evidence Review
Study at a glance

Does having more vitamin D receptors always mean a stronger response?

No. Receptor amount matters, but the response also depends on active vitamin D reaching the cell and on the other machinery needed to act on the signal. A smaller amount of receptor can sometimes be enough.

What controls how much vitamin D receptor a cell has?

Cells can change how much receptor protein they make and how quickly they break it down. These controls vary with the kind of cell and its condition.

Can active vitamin D help the receptor last longer?

In laboratory experiments with activated human immune cells, active vitamin D slowed receptor breakdown. This is evidence for one way receptor levels can change in those cells, not proof that the same effect occurs throughout the body.

Read the full article below ↓

Vitamin D receptor abundance is often discussed as though more receptor must mean a proportionally larger vitamin D response. The evidence does not support that simple linear model. VDR abundance is itself regulated, receptor protein can be stabilised or degraded, and biological competence depends on much more than receptor quantity.

VDR expression is actively regulated

Zella and colleagues mapped regulatory elements controlling the mouse and human VDR genes. Their work identified multiple enhancer regions rather than a single simple promoter switch. This is important because receptor abundance is not merely a fixed property of a tissue: the VDR locus can respond to regulatory inputs and its control architecture differs by cellular context.

The consequence is that two tissues can contain the same receptor gene yet maintain very different receptor abundance. Differences can emerge from enhancer use, transcription-factor environment and the regulatory state of the cell.

Receptor amount is not a direct response meter

Lee and colleagues tested VDR expression in vivo with mouse and human BAC transgenes placed into VDR-null mice. The transgenes reproduced tissue-selective receptor expression and restored major receptor-dependent physiological functions. Crucially, the experimental system shows why receptor abundance and response cannot be treated as a one-to-one relationship: relatively low or restricted expression can remain biologically competent in a defined rescue setting.

This does not mean receptor amount is irrelevant. Very low or absent VDR can clearly become limiting. It means that the dose-response relationship between receptor abundance and physiology depends on tissue, regulatory reserve, ligand exposure and the downstream machinery available in that cell.

Protein stability adds another control layer

Kongsbak and colleagues studied activated human CD4+ T cells and found that vitamin D increased VDR protein partly by protecting the receptor from proteasomal degradation. The work separates receptor transcription from receptor turnover: a cell can alter VDR abundance not only by changing how much receptor it makes, but also by changing how rapidly receptor protein is removed.

The model boundary matters. This proteasomal-stabilisation evidence comes from activated human CD4+ T cells. It should not be presented as a universal mechanism operating identically in every tissue.

Expression, stability and competence are distinct

Three related but different questions therefore need to be kept separate. Expression asks how much VDR transcript or newly produced receptor is generated. Stability asks how long receptor protein persists. Signalling competence asks whether the receptor can participate effectively in ligand recognition, genomic regulation and a biological response.

A tissue can have detectable receptor without strong signalling if ligand, chromatin access or necessary regulatory partners are limiting. Conversely, a relatively modest receptor abundance may be sufficient where downstream machinery is favourable. This is one reason why ‘receptor sensitivity’ cannot be reduced to receptor density alone.

Why this matters for interpreting vitamin D responsiveness

Differences in VDR abundance can contribute to differences in responsiveness, but they are only one component. The genomic response also depends on where VDR can bind, whether regulatory regions are accessible, which cofactors are present and how the cell is otherwise programmed. Tissue physiology then adds further constraints.

The genomic side of this problem is developed in VDR Cistrome, Chromatin and 3D Genome Organisation. The interpretive distinction between receptor presence and response is summarised in Why VDR Presence Is Not the Same as Vitamin D Response.

Common genetic variation is a separate question from receptor abundance and turnover. For the governed evidence on common variants, see Vitamin D Receptor Polymorphisms.

The central interpretation

VDR abundance is a regulated biological variable, not a fixed dial that maps linearly onto response. Enhancer architecture can alter receptor expression; protein turnover can alter receptor persistence; and downstream context determines how much functional signalling a given amount of receptor can support. A useful model of vitamin D responsiveness must therefore distinguish receptor quantity from receptor competence.

For the broader receptor system, return to Vitamin D Receptors.

Primary evidence used in this synthesis

  • Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription · Lee A. Zella, Mark B. Meyer, Robert D. Nerenz, Seong-Min Lee, Melissa L. Martowicz, J. Wesley Pike. PMID 19897601; PMCID PMC2802900; DOI 10.1210/me.2009-0140.
  • The impact of VDR expression and regulation in vivo · Seong-Min Lee, Mark B. Meyer, Nancy A. Benkusky, Charles A. O’Brien, J. Wesley Pike. PMID 28602960; PMCID PMC5723236; DOI 10.1016/j.jsbmb.2017.06.002.
  • Vitamin D Up-Regulates the Vitamin D Receptor by Protecting It from Proteasomal Degradation in Human CD4+ T Cells · Kongsbak M, von Essen MR, Boding L, et al. PMID 24792400; PMCID PMC4008591; DOI 10.1371/journal.pone.0096695.

Related reading

Physiology

Vitamin D Receptor Polymorphisms

Explains how vitamin D receptor polymorphisms contribute to variability in signalling and responsiveness across tissues without predicting outcomes or implying dysfunction.

Read more →

Original sources

Source

The impact of VDR expression and regulation in vivo

The impact of VDR expression and regulation in vivo · Seong-Min Lee, Mark B.

Publication details

The impact of VDR expression and regulation in vivo · Seong-Min Lee, Mark B. Meyer, Nancy A. Benkusky, Charles A. O’Brien, J. Wesley Pike. PMID 28602960; PMCID PMC5723236; DOI 10.1016/j.jsbmb.2017.06.002.

Read more →